Favipiravir is a pyrazinecarboxamide derivative with activity against RNA viruses. Favipiravir is converted to the ribofuranosyltriphosphate derivative by host enzymes and selectively inhibits the influenza viral RNA-dependent RNA polymerase.

It is mainly used for the treatment of new or recurrent influenza in adults (only when other anti-influenza virus drugs are ineffective or poorly effective).